Botox A Injection for Pain after Laparoscopic Ventral Hernia

A Case Report

Dustin Smoot, Martin Zielinski, Donald Jenkins, Henry Schiller

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Introduction. Laparoscopic ventral hernia repair has many advantages over open techniques: adequate visualization of the entire abdominal wall, ease of placement of preperitoneal mesh with adequate overlap, and cosmesis. Intense and activity limiting pain is often one inferior aspect of this repair. We report the case of a patient who was intolerant of narcotic pain medicine with activity limiting pain. A novel technique for postoperative pain control was instituted utilizing Botox A (Allergan Inc., Irvine, CA, USA). Methods. Botox A was diluted to 2 units per mL and three injection sites were chosen on each side of the abdominal wall. All three muscle bellies (external oblique, internal oblique, and transversus) were identified by ultrasound and 8mL was injected in each. This resulted in three muscle layers at six sites for a total of 18 injections. A total of 300 units of Botox A were utilized. Results. Pain scores improved from 10/10 to 2/10 and were durable at 3-month follow up. Conclusion. Botox A provided significant pain control for this patient after laparoscopic ventral hernia repair. Continued prospective study to define long-term outcomes, cost savings, and appropriate timing of injections is underway. Wiley Periodicals, Inc..

Original languageEnglish (US)
Pages (from-to)1121-1123
Number of pages3
JournalPain Medicine
Volume12
Issue number7
DOIs
StatePublished - Jul 2011

Fingerprint

Ventral Hernia
Pain
Injections
Herniorrhaphy
Abdominal Wall
Cost Savings
Narcotics
Postoperative Pain
Medicine
onabotulinumtoxinA
Prospective Studies
Muscles

Keywords

  • Botulinum Toxin A
  • Surgery

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Botox A Injection for Pain after Laparoscopic Ventral Hernia : A Case Report. / Smoot, Dustin; Zielinski, Martin; Jenkins, Donald; Schiller, Henry.

In: Pain Medicine, Vol. 12, No. 7, 07.2011, p. 1121-1123.

Research output: Contribution to journalArticle

Smoot, D, Zielinski, M, Jenkins, D & Schiller, H 2011, 'Botox A Injection for Pain after Laparoscopic Ventral Hernia: A Case Report', Pain Medicine, vol. 12, no. 7, pp. 1121-1123. https://doi.org/10.1111/j.1526-4637.2011.01147.x
Smoot, Dustin ; Zielinski, Martin ; Jenkins, Donald ; Schiller, Henry. / Botox A Injection for Pain after Laparoscopic Ventral Hernia : A Case Report. In: Pain Medicine. 2011 ; Vol. 12, No. 7. pp. 1121-1123.
@article{08f070dffcfb4e0aaf5dfc8390e296b5,
title = "Botox A Injection for Pain after Laparoscopic Ventral Hernia: A Case Report",
abstract = "Introduction. Laparoscopic ventral hernia repair has many advantages over open techniques: adequate visualization of the entire abdominal wall, ease of placement of preperitoneal mesh with adequate overlap, and cosmesis. Intense and activity limiting pain is often one inferior aspect of this repair. We report the case of a patient who was intolerant of narcotic pain medicine with activity limiting pain. A novel technique for postoperative pain control was instituted utilizing Botox A (Allergan Inc., Irvine, CA, USA). Methods. Botox A was diluted to 2 units per mL and three injection sites were chosen on each side of the abdominal wall. All three muscle bellies (external oblique, internal oblique, and transversus) were identified by ultrasound and 8mL was injected in each. This resulted in three muscle layers at six sites for a total of 18 injections. A total of 300 units of Botox A were utilized. Results. Pain scores improved from 10/10 to 2/10 and were durable at 3-month follow up. Conclusion. Botox A provided significant pain control for this patient after laparoscopic ventral hernia repair. Continued prospective study to define long-term outcomes, cost savings, and appropriate timing of injections is underway. Wiley Periodicals, Inc..",
keywords = "Botulinum Toxin A, Surgery",
author = "Dustin Smoot and Martin Zielinski and Donald Jenkins and Henry Schiller",
year = "2011",
month = "7",
doi = "10.1111/j.1526-4637.2011.01147.x",
language = "English (US)",
volume = "12",
pages = "1121--1123",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Botox A Injection for Pain after Laparoscopic Ventral Hernia

T2 - A Case Report

AU - Smoot, Dustin

AU - Zielinski, Martin

AU - Jenkins, Donald

AU - Schiller, Henry

PY - 2011/7

Y1 - 2011/7

N2 - Introduction. Laparoscopic ventral hernia repair has many advantages over open techniques: adequate visualization of the entire abdominal wall, ease of placement of preperitoneal mesh with adequate overlap, and cosmesis. Intense and activity limiting pain is often one inferior aspect of this repair. We report the case of a patient who was intolerant of narcotic pain medicine with activity limiting pain. A novel technique for postoperative pain control was instituted utilizing Botox A (Allergan Inc., Irvine, CA, USA). Methods. Botox A was diluted to 2 units per mL and three injection sites were chosen on each side of the abdominal wall. All three muscle bellies (external oblique, internal oblique, and transversus) were identified by ultrasound and 8mL was injected in each. This resulted in three muscle layers at six sites for a total of 18 injections. A total of 300 units of Botox A were utilized. Results. Pain scores improved from 10/10 to 2/10 and were durable at 3-month follow up. Conclusion. Botox A provided significant pain control for this patient after laparoscopic ventral hernia repair. Continued prospective study to define long-term outcomes, cost savings, and appropriate timing of injections is underway. Wiley Periodicals, Inc..

AB - Introduction. Laparoscopic ventral hernia repair has many advantages over open techniques: adequate visualization of the entire abdominal wall, ease of placement of preperitoneal mesh with adequate overlap, and cosmesis. Intense and activity limiting pain is often one inferior aspect of this repair. We report the case of a patient who was intolerant of narcotic pain medicine with activity limiting pain. A novel technique for postoperative pain control was instituted utilizing Botox A (Allergan Inc., Irvine, CA, USA). Methods. Botox A was diluted to 2 units per mL and three injection sites were chosen on each side of the abdominal wall. All three muscle bellies (external oblique, internal oblique, and transversus) were identified by ultrasound and 8mL was injected in each. This resulted in three muscle layers at six sites for a total of 18 injections. A total of 300 units of Botox A were utilized. Results. Pain scores improved from 10/10 to 2/10 and were durable at 3-month follow up. Conclusion. Botox A provided significant pain control for this patient after laparoscopic ventral hernia repair. Continued prospective study to define long-term outcomes, cost savings, and appropriate timing of injections is underway. Wiley Periodicals, Inc..

KW - Botulinum Toxin A

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=79960381374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960381374&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4637.2011.01147.x

DO - 10.1111/j.1526-4637.2011.01147.x

M3 - Article

VL - 12

SP - 1121

EP - 1123

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 7

ER -